PATENT CLAIM ANALYSIS

Application Number: 16303980
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-07
Patent Classification: ["424", "275100"]

Abstract:
The invention relates to novel immunogenic polypeptides identified in house dust mites and storage mites, which have the potential to be used in allergy immunotherapy, for diagnostic purposes, eventually via production of antibodies binding the polypeptide or for characterising allergen extracts of house dust mites and storage mites.

Claim (Index 75):
The method according to  claim 25 , which comprises at least one of the following modifications:\n a) N-terminal acetylation or methylation b) C terminal amidation c) C-terminal amination d) addition of one to three charged amino acid residues selected from any one of lysine (K), arginine (R), aspartic acid (D), and glutamic acid (E) in the N-terminal or C-terminal e) replacement of one or more hydrogen(s) on the side chain amines of arginine and/or lysine with a methylene group f) glycosylation, and g) phosphorylation.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 98.0
- Lexical Diversity: 1.36842
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15021775', '15532256', '13990858', '12673412', '09662293']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7112055942884956
- 35 USC 102 Novelty (BERT): 0.5210950245909993
- Combined Prediction Score: 0.692194537318746
- Mean Citation Score: 242.401526
- Max Citation Score: 247.44324
- Similarity Product: 143.58248584942817

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test